Better diagnosis and treatment for childhood asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 5 and 16 years old.
- You must have a doctor's diagnosis of asthma and use a daily controller inhaler (like an ICS or combination inhaler).
- Your asthma should be partly controlled or not well controlled at the moment.
- If you are 10 or older, you need to agree to take part, and your parent or guardian must sign a consent form.
- You cannot have had a severe asthma attack in the last 2 weeks or a current lung infection.
- You cannot have another chronic lung disease (like COPD or cystic fibrosis) or very severe asthma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children with wheezing (in younger kids) or doctor-diagnosed asthma (in older kids). It aims to better understand asthma and related breathing problems and how they develop over time.
This study aims to identify specific treatable traits in people with severe asthma and build a personalized treatment plan. It will help doctors understand which treatments might work best for you based on a detailed evaluation.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
This Phase 2 study checks how glycopyrronium bromide works in children with asthma, including its safety and how well inhaler dosing is tolerated. It also uses breathing tests and inhaler technique checks to confirm your child meets key asthma and lung function requirements.
This study tests whether personalized education about your asthma and how to use the Foster Nexthaler inhaler improves your symptoms. It aims to help people whose asthma is not well controlled despite their current medication.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
Hear when a new Asthma Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.